| Non-Hospitalised Patients |
|
N.B. DO NOT PRINT The guidance below is subject to regular review and may change |
| Patient Assessment Flow Chart for nMAB or Antivirals |
| HIGHEST RISK PATIENTS for nMAB and Antiviral (AV) Assessment |
| Notes for Clinicians assessing PL WHIV for COVID Therapies |
| Paxlovid Guidance for Non hospitalised Patients |
| Paxlovid Patient Assessment Guide |
| Sotrovimab Guidance for Non-hospitalised Patients |
| Molnupiravir Guidance for Non-hospitalised Patients |
| UKHSA Molnupiravir Information Leaflet |
| Remdesivir Guidance for High Risk Non-hospitalised Patients |
Back to home page |